Eli Lilly celebrated 150 years, growing from a small Indianapolis lab to a global pharmaceutical giant worth tens of billions ...

U.S.-based drugmaker Eli Lilly on Wednesday launched its Alzheimer's drug ​Lormalzi, also known as Donanemab, in ‌India.

Eli Lilly has introduced Lormalzi in India, a pioneering treatment for Alzheimer's that specifically targets amyloid plaques, ...

Eli Lilly and Novo Nordisk are building cases for their incretin drugs both new and old as attractive weight loss maintenance ...

The Indianapolis-based drugmaker is marking 150 years since Col. Eli Lilly founded his company on May 10, 1876.

Three pharma CEOs joined the $30 million compensation club in 2025 but Eli Lilly’s David Ricks exceeded his nearest peer by ...

INDIANAPOLIS — This May marks 150 years since the founding of Eli Lilly & Company, which has always been based in the heart ...

The Parkland School Board tabled a vote on a tax break for Eli Lilly and indicated the controversial resolution will be ...

In a press release via PR Newswire, Lilly said the initiative launched Tuesday and will support HATCH, United Way Worldwide, ...

After a stunning Q1 earnings report and raised full-year guidance, the question is whether the valuation has run ahead of ...

Phase IIIb SURMOUNT-Maintain showed near-complete weight-loss maintenance on maximum tolerated tirzepatide through Week 112, while a 5 mg step-down dose was associated with 5.6 kg mean regain.

Eli Lilly (LLY) on Wednesday rolled out its Alzheimer’s therapy donanemab under the brand name Lormalzi in India, where the percentage of patients affected by the memory-robbing disease is fast rising ...